ClinicalTrials.Veeva

Menu

Relationship of Cerebral Perfusion Pressure Variability to Sepsis-associated Encephalopathy

K

Kang Yan

Status

Completed

Conditions

Sepsis

Treatments

Other: no interventions

Study type

Observational

Funder types

Other

Identifiers

NCT02288715
CPPV-KYan1205

Details and patient eligibility

About

The purpose of the study is to evaluate whether variability of CPP (cerebral perfusion pressure) is related to sepsis-associated encephalopathy and outcomes of patients with sepsis.

Full description

Encephalopathy is a common complication of sepsis, impaired cerebrovascular autoregulation (AR) in patients with sepsis is considered related to Sepsis-associated encephalopathy (SAE). As AR is important in stabilizing the cerebral perfusion pressure, whether greater variability of CPP is related to SAE and mortality or not remains unclear. We conduct this study to evaluate the relationship between them.

Enrollment

110 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • clinical symptoms of sepsis, severe sepsis and septic shock
  • age over 18 years

Exclusion criteria

  • preexisting Neurological diseases
  • traumatic brain injury
  • intracranial infectious disease
  • severe hepatic or renal dysfunction
  • ICU discharge Within 72 hours
  • pregnancy

Trial design

110 participants in 2 patient groups

SAE
Description:
patient who develop encephalopathy in the progress of sepsis
Treatment:
Other: no interventions
non-SAE
Description:
patient who do not develop encephalopathy in the progress of sepsis
Treatment:
Other: no interventions

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems